BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

Lorenzo Bertani  1     Luca Antonioli     Marco Fornili     Vanessa D'Antongiovanni     Francesca Coppini     Ceccarelli Linda  2     Laura Benvenuti     Maria Gloria Mumolo     Laura Baglietto     Massimo Bellini     Matteo Fornai     Nicola de Bortoli     Francesco Costa    
1 University of Pisa, Pisa, Italy
2 Pisa University Hospital, Pisa, Italy

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing